尼妥珠单抗联合DCF方案治疗晚期胃癌1例
摘要
随着新的化疗药物的不断出现,晚期胃癌的化疗已经具有较多的选择。但是,无论是在近期疗效还是在远期生存期上,其结果尚未能令人满意。靶向表皮生长因子受体(EGFR)药物的问世,使多种实体肿瘤的治疗效果得到了明显的提高。我科采用尼妥珠单抗联合DCF方案治疗晚期残胃癌伴肝多发转移1例取得良好的疗效,现报告如下。
出处
《癌症进展》
2011年第4期453-454,共2页
Oncology Progress
参考文献5
-
1Cutsem E V. Novel cytotoxic regimens in gastric cancer [J]. Eur J Cancer Supplements. 2006, 4 (10): 14.
-
2Ozdemir NY, Aball H, Budakoglu B, et al. The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-flu- orouracil in the first-line treatment of advanced stage gastric [J]. Med Oncol, 2009, Epub ahead of print.
-
3Boland WK, Bebb G. Nimotuzumab: a novel anti-EGFR monoclonal antibody that retains anti-EGFR activity while minimizing skin toxicity [ J ]. Expert Opin Biol Ther,2009, 9 (9):1199.
-
4Pinto C, Siena S, Barone C, et al. Cetuximab in combi- nation with cisplatin and docetaxel as first-line treatment in patients with locally advanced or metastatic gastric or gas- troesophageal junction (GEJ) adenocarcinoma (Italian phase II DOCETUX study) [ J ]. J Clin Oncol, 2008, 26 (suppl) : Abstr 4575.
-
5Rao S, Starling N, Cunningham D, et al. Phase I study of epirubicin, cisplatin and eapecitabine plus matuzumab in previously untreated patients with advanced oesophagogastrie cancer [ J]. Br J Cancer, 2008, 99 (6) : 868.
-
1林彩玲,陈晓耕,林镇和.多学科治疗结直肠癌伴肝多发转移的近期疗效观察[J].吉林医学,2014,35(32):7183-7184.
-
2阿地力.克然木,郑洪途,刘方奇,蔡三军,徐烨.乙状结肠癌侵犯膀胱伴同时性肝多发转移一例[J].中华结直肠疾病电子杂志,2017,6(1):68-71. 被引量:2
-
3王凯,张允,雷景伟,孟欢,周伟,陈菊花.肝多发转移瘤CT平扫加增强的诊断分析[J].中国社区医师(医学专业),2010,12(12):121-122.
-
4王长久,兰玉林,卜迎光.恶性胰岛细胞瘤肝多发转移1例[J].牡丹江医学院学报,2000,21(2):70-71.
-
5蔡君,杨继元,李爽,李晶晶.腹膜后实性假乳头状瘤术后肝多发转移1例[J].肿瘤学杂志,2011,17(7):559-560. 被引量:1
-
6牛克松,肖萤,廖锦堂,谭化冰,庄承成,李小松.胃肠道间质细胞瘤的超声表现[J].中华医学超声杂志(电子版),2005,2(4):231-232. 被引量:5
-
7李春元,董智.脾血管内皮肉瘤并肝多发转移一例[J].临床放射学杂志,2003,22(6):500-500.
-
8李梅,谭煌英.胰腺胃泌素瘤伴肝多发转移1例[J].中日友好医院学报,2016,30(2):122-123.
-
9吴东德,聂磊,夏晓勤,符常波.功能性恶性嗜铬细胞瘤肝多发转移手术切除一例[J].中华肝胆外科杂志,2009,15(2):116-116. 被引量:1
-
10汤文.肝多发转移瘤CT平扫加增强20例诊断分析[J].当代医学,2012,18(33):66-67.